Lisa C. Zaba MD, PhDClinical Associate Professor, Department of Dermatology, Stanford University, Palo Alto, California; Director, Stanford Multidisciplinary Merkel Cell Carcinoma Clinic; Director, Supportive Oncodermatology, Stanford South Bay Cancer Center, San Jose, California
Dr. Lisa Zaba is a Clinical Associate Professor in the Department of Dermatology and works at the Stanford Cancer Centers in Palo Alto and South Bay.
She grew up in Salt Lake City, Utah, attended Stanford University and then obtained an MD and PhD at Cornell and the Rockefeller University, respectively. Her love of inflammatory skin conditions was developed during her PhD training studying psoriasis and figuring out the underlying pathways for this disease that led to the development of targeted biologic medications for psoriasis. The love of taking care of patients with cancer began during her internship at Memorial Sloan Kettering and continued on through dermatology residency at Stanford.
She established a multi-disciplinary Merkel cell carcinoma clinic at Stanford in 2018, and currently leads a clinical and basic science research team studying this disease, as well as a multicenter Merkel cell consortium. The first line treatment for metastatic Merkel cell carcinoma is immune-checkpoint inhibition, and she also studies immune-related adverse events (irAEs) from these medications.
Dr. Zaba is dedicated to translational study of Merkel cell cancer and the intersection of cancer and immunology, and feels very grateful to her patients and colleagues for their collaboration, as we strive to improve the lives of patients with cancer.